Overview
Daniel Angelov practices practicing medicine in Dublin, Ireland.
His clinical expertise encompasses Mediastinal Tumor, Cutaneous T-Cell Lymphoma (CTCL), and T-Cell Lymphoma.
He is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Gender
Locations
Dublin, L, Ireland
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Daniel Angelov
Is Daniel Angelov a top-rated expert for Mediastinal Tumor?
MediFind is an objective health platform that identifies experts based on real-world data. Daniel Angelov is classified as an Experienced expert for Mediastinal Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Daniel Angelov participate in research or clinical trials?
Yes. Daniel Angelov has published 8 articles and abstracts on conditions like Mediastinal Tumor. You can view a list of Daniel Angelov's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cutaneous T-Cell Lymphoma (CTCL)Mr. Angelov isExperienced. Learn about Cutaneous T-Cell Lymphoma (CTCL).
- Mediastinal TumorMr. Angelov isExperienced. Learn about Mediastinal Tumor.
- T-Cell LymphomaMr. Angelov isExperienced. Learn about T-Cell Lymphoma.